As from previous immunogenicity studies with DNA vectors expressing Nefmut fused with several viral and tumor antigens, HPV-16 E7 reproducibly appeared the antigen eliciting the most potent CD8+ T cell response [31,37]. This evidence concerns the gene CD8A and neoplasm.